Koyfin Home > Directory > Health Care > Aeglea Biothera > Net Debt / EBITDA

Aeglea Biothera Net Debt / EBITDA Chart (AGLE)

Aeglea Biothera annual/quarterly Net Debt / EBITDA from 2014 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Aeglea Biothera Net Debt / EBITDA for the quarter ending June 06, 2020 was $2m a 46.92% increase of 1m year over year
  • Aeglea Biothera Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $2m a 37.61% increase of 1m year over year
  • Aeglea Biothera Annual Net Debt / EBITDA for 2019 was $1m a -94.06% decrease of -1m from 2018
  • Aeglea Biothera Annual Net Debt / EBITDA for 2018 was $2m a -11.17% decrease of 0m from 2017
  • Aeglea Biothera Annual Net Debt / EBITDA for 2017 was $2m a -59.03% decrease of -1m from 2016
Other Ratios Metrics:
  • Aeglea Biothera Other Liabilities for the quarter ending December 12, 2018 was $0m a -40.28% decrease of 0m year over year
View Chart On Koyfin

Quarterly AGLE Net Debt / EBITDA Data

06/2020$2m
03/2020$1m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$2m
12/2018$1m
09/2018$1m
06/2018$2m
03/2018$1m

Annual AGLE Net Debt / EBITDA Data

2019$1m
2018$2m
2017$2m
2016$3m
2015$3m
2014$0m